https://orcid.org/0000-0001-6811-9356
REFERENCES
- Friesen, P., L. Gelinas, A. Kirby, D. H. Strauss, and B. E. Bierer. 2023. IRBs and the protection-inclusion dilemma: Finding a balance. The American Journal of Bioethics 23 (6):75–88. doi:10.1080/15265161.2022.2063434.
- Lidz, C. W., E. Pivovarova, P. Appelbaum, D. F. Stiles, A. Murray, and R. L. Klitzman. 2018. Reliance agreements and single IRB review of multisite research: Concerns of IRB members and staff. The American Journal of Bioethics Empirical Bioethics 9 (3):164–72. doi:10.1080/23294515.2018.1510437.
- Rid, A., E. J. Emanuel, and D. Wendler. 2010. Evaluating the risks of clinical research. JAMA 304 (13):1472–9. doi:10.1001/jama.2010.1414.
- Rid, A., and D. Wendler. 2011. A proposal and prototype for a research risk repository to improve the protection of research participants. Clinical Trials 8 (6):705–15. doi:10.1177/1740774511414595.
- US Government Accountability Office. 2023. Report to congressional requesters. Institutional Review Boards: Actions needed to improve federal oversight and examine effectiveness. GAO 23 104721. Accessed March 15, 2023. https://www.gao.gov/assets/gao-23-104721.pdfm.